.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Merck
Colorcon
Argus Health
Daiichi Sankyo
Queensland Health
Cipla
Citi
Novartis
Julphar

Generated: June 29, 2017

DrugPatentWatch Database Preview

SODIUM BUTABARBITAL Drug Profile

« Back to Dashboard

What is the patent landscape for Sodium Butabarbital, and what generic Sodium Butabarbital alternatives are available?

Sodium Butabarbital is a drug marketed by Hikma Pharms Llc, Marshall Pharma, Ivax Sub Teva Pharms, and Lannett. and is included in nine NDAs.

The generic ingredient in SODIUM BUTABARBITAL is butabarbital sodium. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the butabarbital sodium profile page.

Summary for Tradename: SODIUM BUTABARBITAL

Patents:0
Applicants:4
NDAs:9
Bulk Api Vendors: see list21
Clinical Trials: see list2,344
Patent Applications: see list1,662
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SODIUM BUTABARBITAL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Pharms Llc
SODIUM BUTABARBITAL
butabarbital sodium
TABLET;ORAL085418-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Lannett
SODIUM BUTABARBITAL
butabarbital sodium
TABLET;ORAL085866-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Ivax Sub Teva Pharms
SODIUM BUTABARBITAL
butabarbital sodium
TABLET;ORAL084040-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Lannett
SODIUM BUTABARBITAL
butabarbital sodium
TABLET;ORAL085881-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Marshall Pharma
SODIUM BUTABARBITAL
butabarbital sodium
TABLET;ORAL083524-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Dow
Express Scripts
Julphar
Mallinckrodt
Fuji
US Department of Justice
Merck
Chubb
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot